India

COVID-19 Coronavirus Pandemic – Latest Media Coverage

"BioNTech Covid"

Latest news and video coverage curated from trusted media outlets


0 shares	Share Tweet Save Post Send


DNA contamination in COVID jabs exceeds allowable limit by up to 384x, laboratory finds Prof. Brigitte König of the Magdeburg University in Germany has researched Pfizer-BioNTech COVID jab fluid from 5 different batches for DNA contamination. All batches turn out to be significantly.. Credit: Rumble Duration: 11:26Published on February 19, 2024

You Might Like

Worldwide: Moderna Sues Pfizer / BioNTech For COVID Vaccine Patent Infringement - Dennemeyer Group On August 26, 2022, biotechnology company Moderna filed lawsuits against pharmaceutical giant Pfizer and its German partner BioNTech for the alleged infringement of patented mRNA technology in the.. Mondaq - Published on September 2, 2022
Pfizer-BioNTech Covid shot 73.2% effective in kids under 5, states new data Pfizer Inc's Covid-19 vaccine was 73.2% effective in children aged between 6 months and 4 years, the company's data showed on Tuesday, two months after the US rollout of the shots began for that age.. IndiaTimes - Published on August 23, 2022
FDA authorises second booster of Pfizer/BioNTech Covid shot The United States regulators authorised a second booster dose of Pfizer Inc and BioNTech SE's Covid-19 vaccine for people 50 and older due to concerns about waning immunity in the age group, the.. IndiaTimes - Published on March 29, 2022

FDA to discuss Pfizer-BioNTech Covid vax for kids under 5 newKerala.com - Published on February 3, 2022
'Three doses of Pfizer-BioNTech COVID-19 vaccine neutralizes Omicron variant' newKerala.com - Published on December 10, 2021Also reported by •Zee News •DNA
EU watchdog approves first COVID-19 vaccine for kids aged 5-11 years The Pfizer BioNTech COVID-19 vaccine received approval for use in children 5-11 on Thursday. DNA - Published on November 25, 2021

Pfizer says its COVID-19 vaccine 90.7% effective in kids Pfizer and its partner BioNTech said their Covid-19 vaccine is safe and 90.7 per cent effective against symptomatic coronavirus in children aged 5-11. DNA - Published on October 23, 2021
Pfizer's BIG claim on COVID-19 vaccine for children Pfizer and its partner BioNTech said their Covid-19 vaccine is safe and 90.7 per cent effective against symptomatic coronavirus in children aged 5-11. DNA - Published on October 23, 2021
‘Pfizer vax provides 90% protection against hospitalisation for 6 months’ The Pfizer-BioNTech Covid vaccine is 90% effective at preventing hospitalisation for up to six months, with no signs of waning during that time period, according to a large new US study conducted by.. IndiaTimes - Published on October 6, 2021
EU regulator OKs Pfizer vaccine booster for 18 and older The European Union's drug regulator gave its backing Monday to booster shots of the Pfizer-BioNTech Covid-19 vaccine for people 18 and older. The European Medicines Agency said the booster doses “may.. IndiaTimes - Published on October 4, 2021

New Zealand reports first death linked to Pfizer/BioNTech COVID-19 vaccine Indian Express - Published on September 4, 2021
FDA grants full approval to Pfizer-BioNTech Covid vaccine Indian Express - Published on August 23, 2021
Myocarditis disease linked to COVID vaccine Inflammation and swelling of the heart, a condition known as myocarditis, has been identified in many youngsters who have received their dose of Pfizer-BioNTech COVID-19 vaccine. IndiaTimes - Published on June 12, 2021	COVID-19: Pfizer produces less antibodies against Delta variant first found in India, says Lancet The study analysed antibodies in the blood of 250 healthy people who received either one or two doses of the Pfizer-BioNTech COVID-19 vaccine, up to three months after their first dose. Zee News - Published on June 5, 2021
UK approves Pfizer/BioNTech COVID shot for 12-15 year-olds newKerala.com - Published on June 5, 2021Also reported by •Indian Express	EU clears Pfizer-BioNTech Covid-19 vaccine for adolescents Indian Express - Published on May 29, 2021
Discussions underway with GOI for supply of Pfizer-BioNTech COVID vaccine, says Pfizer newKerala.com - Published on May 25, 2021	Singapore approves use of Pfizer-BioNTech COVID vaccine on teenagers aged 12-15 The authorities in Singapore have approved the use of the Pfizer-BioNTech COVID vaccine on teenagers aged 12 to 15. According to reports, Singapore city’s State Health Sciences Authority has cleared.. Zee News - Published on May 19, 2021
COVID-19: US CDC allows use of Pfizer vaccine for 12-15 years old An advisory panel of the Centres for Disease Control and Prevention recommended the use of the Pfizer-BioNTech COVID-19 vaccine for children aged between 12 and 15 in the US. Zee News - Published on May 13, 2021	US authorises Pfizer/BioNTech Covid-19 vaccine for children 12 to 15 Indian Express - Published on May 11, 2021